عنوان

The Atypical Mycobacteria and Human Mycobacteriosis.

(Number (ISBN

146842310X

(Number (ISBN

9781468423105

Number

b552289

Title Proper

The Atypical Mycobacteria and Human Mycobacteriosis.

General Material Designation

[Book]

First Statement of Responsibility

Chapman, John.

Name of Publisher, Distributor, etc.

Springer Verlag

Date of Publication, Distribution, etc.

2012

Text of Note

I. General Characteristics.- 1. Early History of the Atypical Mycobacteria.- I. Isolations from Milk Products.- II. Isolations from the Environment.- III. Early Veterinary Mycobacteriology.- IV. Isolations from Human Material.- V. A Latent Period in Mycobacteriology.- VI. Human Infection by Avian or Avianlike Mycobacteria.- VII. Epidemiological Evidence for "Saprophytic" Infection of Humans.- VIII. Classification.- IX. Origin of the Atypical Mycobacteria.- 2. Bacteriology.- I. Cultural Characteristics.- A. Media.- B. Rate of Growth.- C. Oxygen and CO2 Requirements.- D. Temperature Requirements.- E. Hydrogen Ion Concentration.- F. Colonial Morphology and Pigmentation.- G. Cording and Orientation.- II. Biochemical Activity.- A. The Niacin Test.- B. Catelase Production.- C. Tween Hydrolysis.- D. Nitrate Reductase.- E. Amidases.- F. Arylsulfatase.- G. Reduction of Tellurite.- H. Other Biochemical Tests.- I. Mycobacterial Resistance.- J. Adansonian Classification.- III. Chemical Studies.- IV. Physical Methods.- V. Biological Methods.- A. Bacteriophage Typing.- B. Hemagglutination.- C. Precipitins.- D. Agglutinins and Agglutinin Absorption.- E. Other Methods.- 3. Epidemiology.- I. Sources in the Environment.- A. Soil.- B. Water.- II. Human Foodstuffs.- III. Mycobacteriosis of Animals.- IV. Skin Testing in Humans.- V. Serological Studies.- 4. Pathology and Pathogenesis.- I. Pulmonary Pathology.- II. Pathology of Lymph Nodes.- III. Pathology of Other Tissues.- IV. Pathogenicity for Animals.- V. Pathogenesis in Humans.- II. The Photochromogenic Mycobacteria.- 5. Mycobacterium kansasii (Hauduroy).- I. Bacteriology.- II. Pathology.- III. Epidemiology.- A. Isolations from Environmental and Nonhuman Sources.- B. Human Isolations.- 1. Geography.- 2. Age.- 3. Sex.- 4. Race.- 5. Occupational and Socioeconomic Factors.- 6. Associated Pulmonary Disease.- IV. Clinical Features.- A. "Primary" Infection of the Lung.- B. Pulmonary Disease in Adults.- 1. Symptoms.- 2. Physical Signs.- 3. Laboratory Findings.- 4. Roentgenography.- 5. Diagnosis and Differential Diagnosis.- C. Disease of the Lymph Nodes.- D. Cutaneous Disease.- E. Disease of Bone and Soft Tissue.- F. Disease of the Genitourinary System.- G. Disseminated Disease.- V. Susceptibility of M. kansasii and Treatment.- A. In Vitro Tests.- B. In Vivo Studies.- C. Results of Clinical Treatment.- 6. Mycobacterium marinum (balnei).- I. Bacteriology.- II. Epidemiology.- III. Pathology.- IV. Clinical Features.- V. Treatment.- 7. Mycobacterium simiae.- I. Bacteriology.- II. Pathology and Pathogenesis.- III. Epidemiology.- IV. Clinical Features.- V. Susceptibility and Therapy.- III. The Scotochromogenic Mycobacteria.- 8. Mycobacterium scrofulaceum.- I. Bacteriology.- II. Pathology and Pathogenesis.- III. Epidemiology.- A. Environment.- B. Secretions and Tissues of Healthy Humans.- C. Human Reactions to Sensitins.- D. Distribution of Human Disease.- 1. Geography.- 2. Age, Sex, Race, and Family.- 3. Associated Disease.- IV. Clinical Features.- A. Lymph Nodes.- B. Lung and Pleura.- C. Cutaneous Lesions.- D. Bone and Soft Tissue.- E. Disseminated Disease.- V. Susceptibility and Treatment.- A. Tests in Vitro.- B. Effects in Human Disease.- 9. Mycobacterium szulgai.- I. Bacteriology.- II. Pathology.- III. Epidemiology.- IV. Clinical Features.- V. Susceptibility and Treatment.- IV. The Nonphotochromogenic Mycobacteria.- 10. The Avium-Battey Complex.- I. Bacteriology.- II. Pathology and Pathogenesis.- III. Epidemiology.- A. Isolations from the Environment and from Food.- B. Isolations from Animals.- C. Human Isolations and Hypersensitivity.- 1. Skin Tests.- 2. Cultures from Healthy People.- 3. Epidemiology of Disease.- a. Geography.- b. Age.- c. Sex.- d. Race.- e. Occupational and Social Factors.- f. Associated Disease.- g. Familial Occurrence.- h. Other Factors.- IV. Clinical Features.- A. "Primary" Infection.- B. Pulmonary Disease in Adults.- 1. Symptoms.- 2. Physical Findings.- 3. Laboratory Findings.- 4. Roentgenographic Examination.- 5. Differential Diagnosis.- C. Disease of Lymph Nodes.- D. Cutaneous Disease.- E. Bones and Soft Tissues.- F. Genitourinary Tract.- G. Disseminated Disease.- V. Susceptibility and Treatment.- A. Tests in Vitro.- B. Trials in Vivo.- C. Experience in Human Disease.- VI. Other Group III Infections.- 11. Mycobacterium xenopi.- I. Bacteriology.- II. Pathology and Pathogenesis.- III. Epidemiology.- A. Lower Animals.- B. Environment.- C. Geography.- D. Sex.- IV. Clinical Features.- V. Susceptibility and Treatment.- V. The Rapidly Growing Mycobacteria.- 12. Mycobacterium fortuitum (with M. chelonei, M. borstelense, and M. abscessus).- I. Nomenclature.- II. Bacteriology.- III. Pathology.- A. The Lungs.- B. Skin and Subcutaneous Tissue.- C. The Cornea.- D. Other Tissues.- E. Histology.- IV. Clinical Manifestations.- A. Superficial Abscesses.- B. Pulmonary Disease.- C. Disseminated Infection.- D. Corneal Infection.- V. Treatment.- A. Subcutaneous Abscesses.- B. Pulmonary Lesions.- C. Susceptibility of M. fortuitum and Antimicrobial Therapy.- 13. Mycobacterium ulcerans.- I. Bacteriology.- II. Pathology and Pathogenesis.- III. Epidemology.- A. Geographic Distribution.- B. Age.- C. Sex.- D. Other Factors.- IV. Clinical Features.- V. Treatment.- VI. Appendix.- Appendix A. The Mycobacteria in Clinical Specialties.- Appendix B. Alternate Classifications of Atypical Mycobacteria.- Appendix C. Drugs: Dosages, Toxicities, and Combinations.- References.

Class number

Book number

Chapman, John.

Chapman, John.

Electronic name

[Book]

Y